Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M, Bulai-Livideanu C, Baran R, Ortonne JP, Richert B, Tosti A, Piraccini BM, Szepietowski JC, Sibaud V, Coubetergues H, Voisard JJ, Paul C. Lahfa M, et al. Among authors: voisard jj. Dermatology. 2013;226(1):5-12. doi: 10.1159/000345105. Epub 2013 Mar 1. Dermatology. 2013. PMID: 23467055 Clinical Trial.
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis.
Paul C, Coustou D, Lahfa M, Bulai-Livideanu C, Doss N, Mokthar I, Turki H, Nouira R, Fazaa B, Ben Osman A, Zourabichvili O, Cazeau C, Coubetergues H, Picot S, Bienvenu AL, Voisard JJ. Paul C, et al. Among authors: voisard jj. Dermatology. 2013;227(2):157-64. doi: 10.1159/000353667. Dermatology. 2013. PMID: 24051622 Clinical Trial.
[Management of presumed onychomycosis in private practice].
Duhard E, Coudière P, Voisard JJ, Allaert FA. Duhard E, et al. Among authors: voisard jj. Ann Dermatol Venereol. 2006 Jan;133(1):11-5. doi: 10.1016/s0151-9638(06)70835-3. Ann Dermatol Venereol. 2006. PMID: 16495844 French.
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial.
Stockfleth E, Jouary T, Farnetani F, Pascual AM, De Almeida Agudo C, Voisard JJ, Bégeault N, Delarue A. Stockfleth E, et al. Among authors: voisard jj. Dermatol Ther (Heidelb). 2023 Apr;13(4):1013-1027. doi: 10.1007/s13555-023-00902-6. Epub 2023 Mar 1. Dermatol Ther (Heidelb). 2023. PMID: 36856965 Free PMC article.
Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.
Baselga E, Dembowska-Baginska B, Przewratil P, González-Enseñat MA, Wyrzykowski D, Torrelo A, López Gutiérrez JC, Rychłowska-Pruszyńska M, de Lucas-Laguna R, Esteve-Martinez A, Roé E, Zaim M, Menon Y, Gautier S, Lebbé G, Bouroubi A, Delarue A, Voisard JJ. Baselga E, et al. Among authors: voisard jj. Pediatrics. 2018 Sep;142(3):e20173866. doi: 10.1542/peds.2017-3866. Epub 2018 Aug 6. Pediatrics. 2018. PMID: 30082451 Clinical Trial.
Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.
Del Frari L, Léauté-Labrèze C, Guibaud L, Barbarot S, Lacour JP, Chaumont C, Delarue A, Voisard JJ, Brunner V. Del Frari L, et al. Among authors: voisard jj. Pharmacol Res Perspect. 2018 Apr 30;6(3):e00399. doi: 10.1002/prp2.399. eCollection 2018 Jun. Pharmacol Res Perspect. 2018. PMID: 29736244 Free PMC article.
20 results